Beam Therapeutics Inc
(BEAM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 234,700 | 109,500 | 8,900 | 245,300 | 524,900 |
| Depreciation Amortization | 192,100 | 132,800 | 74,100 | 265,500 | 199,100 |
| Income taxes - deferred | -15,400 | -17,700 | -6,100 | -66,300 | 40,800 |
| Accounts receivable | 112,900 | 6,200 | 58,900 | 124,300 | 50,600 |
| Accounts payable and accrued liabilities | 2,500 | 24,100 | -32,500 | -62,400 | N/A |
| Other Working Capital | 136,800 | -38,800 | -190,800 | -318,500 | -449,900 |
| Other Operating Activity | -49,300 | 15,900 | -15,000 | 629,700 | 263,800 |
| Operating Cash Flow | $614,300 | $232,000 | $-102,500 | $817,600 | $629,300 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -9,800 | N/A |
| PPE Investments | -76,800 | -49,400 | -26,300 | -157,100 | -94,900 |
| Net Acquisitions | -77,600 | -77,600 | N/A | -107,300 | -104,100 |
| Purchase Of Investment | -41,700 | -22,000 | -29,000 | N/A | N/A |
| Sale Of Investment | 58,400 | 37,600 | N/A | N/A | N/A |
| Investing Cash Flow | $-137,700 | $-111,400 | $-55,300 | $-274,200 | $-199,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -3,600 | 4,400 | -1,000 | -197,000 | 658,700 |
| Debt Issued | 895,800 | 896,100 | 688,000 | 790,000 | N/A |
| Debt Repayment | -1,194,300 | -849,400 | -394,800 | -205,800 | -204,800 |
| Common Stock Issued | 4,900 | 3,400 | 1,500 | 21,500 | 15,300 |
| Common Stock Repurchased | N/A | N/A | N/A | -278,600 | -278,600 |
| Dividend Paid | -123,500 | -94,900 | -66,200 | -261,200 | -195,100 |
| Other Financing Activity | 400 | 300 | 100 | -424,700 | -452,000 |
| Financing Cash Flow | $-420,300 | $-40,100 | $227,600 | $-555,800 | $-456,500 |
| Exchange Rate Effect | 40,500 | 20,800 | 7,000 | -28,000 | -2,000 |
| Beginning Cash Position | 163,300 | 163,300 | 163,300 | 203,700 | 203,700 |
| End Cash Position | 260,100 | 264,600 | 240,100 | 163,300 | 175,500 |
| Net Cash Flow | $96,800 | $101,300 | $76,800 | $-40,400 | $-28,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 614,300 | 232,000 | -102,500 | 817,600 | 629,300 |
| Capital Expenditure | -91,200 | -57,900 | -27,000 | -176,300 | -106,100 |
| Free Cash Flow | 523,100 | 174,100 | -129,500 | 641,300 | 523,200 |